<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00308230</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00045884</org_study_id>
    <nct_id>NCT00308230</nct_id>
  </id_info>
  <brief_title>Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)</brief_title>
  <official_title>A Pilot Study of B-Type Natriuretic Peptide (BNP) Levels in Patients With Congenital Heart Disease and Systemic Right Ventricles or Volume Overloaded Pulmonic Right Ventricles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The object of this study is to measure the levels of B-type Natriuretic Peptide (BNP) in
      patients with congenital heart disease, normal individuals, and patients with acquired heart
      failure, and compare the results from each group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrollment: Patients with congenital heart disease seen at Emory Clinics, Adult Congenital
      Heart Disease program, Crawford Long Hospital will be asked to participate in this pilot
      study. Sample size: 20 patients (5 in each group) Screening Phase: Demographic data, medical
      history, physical examination including vital signs and room air oxygen saturation, and
      medications will be recorded. New York Heart association functional class will be recorded.

      BNP Levels: Approximately 7 cc of blood will be collected. The blood will be analyzed for
      B-type natriuretic peptide on a rapid assay in the clinic.

      Exercise Tolerance: will be measured by a 6 minute walk test on day of visit Echocardiogram:
      A complete echocardiogram including assessment of anatomy, ventricular function and valvular
      function will be performed following the phlebotomy.

      Quality of life: The minnesota living with heart failure questionnaire will be administered
      on the day of collection of neurohormonal levels. A research nurse will be available to
      assist the patient if needed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2001</start_date>
  <completion_date type="Actual">September 2004</completion_date>
  <primary_completion_date type="Actual">March 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BNP Levels</measure>
    <time_frame>1 day</time_frame>
    <description>Levels of B-type naturietic peptide in the blood</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Normal Heart</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control Group with Normal Heart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Congenital Heart Disease</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tetralogy of Fallot, DTGA, CCTGA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Left ventricular heart failure, no congestive heart disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Six minute walk test</intervention_name>
    <arm_group_label>Normal Heart</arm_group_label>
    <arm_group_label>Congenital Heart Disease</arm_group_label>
    <arm_group_label>Heart Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Minnesota Living with Heart Failure Questionnaire</intervention_name>
    <arm_group_label>Normal Heart</arm_group_label>
    <arm_group_label>Congenital Heart Disease</arm_group_label>
    <arm_group_label>Heart Failure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Patients with a systemic right ventricle and a subpulmonic left
        ventricle-including patients with transposition of the great arteries (d-TGA) who have
        undergone Mustard and Senning repairs (atrial switch procedures) and patients with
        congenitally corrected TGA (l-TGA) Subpulmonic right ventricle in the absence of pulmonary
        hypertension (repaired tetralogy of Fallot, congenital pulmonic regurgitation) 4-chambered
        heart Age &gt; 18 years Participants will have either acquired left ventricular dysfunction
        (ejection fraction &lt; 35%) or no known cardiac disease For the control group, individuals
        will have normal cardiac anatomy and normal left ventricular function (determined by
        echocardiogram) and no known cardiac disease.

        Exclusion Criteria:

        Single ventricle and or single atria Liver disease with portal hypertension Renal disease
        requiring dialysis Creatine &gt; 4.0 Significant pulmonary hypertension (systolic PAP &gt;60 mmHg
        by Echo) Uncontrolled systemic arterial hypertension (systolic &gt; 200 mmHg or diastolic &gt;105
        mmHg) Myocardial infarction or acute coronary syndrome within 2 months D-TGA status post
        atrial switch procedure (Jatene) Intracardiac shunts Inadequate echocardiogram windows
        Coronary Angioplasty 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy M Book, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2006</study_first_submitted>
  <study_first_submitted_qc>March 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2006</study_first_posted>
  <results_first_submitted>September 10, 2013</results_first_submitted>
  <results_first_submitted_qc>July 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 17, 2014</results_first_posted>
  <last_update_submitted>July 16, 2014</last_update_submitted>
  <last_update_submitted_qc>July 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Wendy M. Book</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Congenital, BNP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>medical specialty clinic</recruitment_details>
      <pre_assignment_details>No washout or run-in period. Participants were stable Ambulatory outpatients with no changes in their medical regimen for prior to enrollment.
Exclusions included inability to complete a six minute walk, inability to cooperate with instructions, congenital diagnosis other than the three listed in the CHD group (TOF, DTGA, CCTGA)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Structurally normal heart without heart disease.</description>
        </group>
        <group group_id="P2">
          <title>Congenital Heart Disease</title>
          <description>Tetralogy of Fallot, d-transposition of the great arteries, congenitally corrected transposition of the great arteries</description>
        </group>
        <group group_id="P3">
          <title>Heart Failure</title>
          <description>Acquired left ventricular heart failure, no history of congenital heart disease</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Structurally normal heart without heart disease</description>
        </group>
        <group group_id="B2">
          <title>Congenital Heart Disease</title>
          <description>Tetralogy of Fallot, d-transposition of the great arteries, congenitally corrected transposition of the great arteries</description>
        </group>
        <group group_id="B3">
          <title>Heart Failure</title>
          <description>Acquired left ventricular heart failure, no history of congenital heart disease</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>BNP Levels</title>
        <description>Levels of B-type naturietic peptide in the blood</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Structurally normal hearts</description>
          </group>
          <group group_id="O2">
            <title>Congenital Heart Disease</title>
            <description>TOF, DTGA, CCTGA-tetralogy of Fallot, the transposition of the great arteries, congenitally corrected transposition</description>
          </group>
          <group group_id="O3">
            <title>Heart Failure</title>
            <description>Left ventricular failure</description>
          </group>
        </group_list>
        <measure>
          <title>BNP Levels</title>
          <description>Levels of B-type naturietic peptide in the blood</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.3" spread="17.3"/>
                    <measurement group_id="O2" value="42.4" spread="44.8"/>
                    <measurement group_id="O3" value="384.3" spread="452.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Structurally normal heart without heart disease</description>
        </group>
        <group group_id="E2">
          <title>Congenital Heart Disease</title>
          <description>Tetralogy of Fallot, d-transposition of the great arteries, congenitally corrected transposition of the great arteries</description>
        </group>
        <group group_id="E3">
          <title>Heart Failure</title>
          <description>Acquired left ventricular heart failure, no history of congenital heart disease</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Wendy Book</name_or_title>
      <organization>Emory University</organization>
      <phone>404-778-5545</phone>
      <email>wbook@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

